In addition, a meta-analysis by Zhao et al. identified serum IL-10 as a negative prognostic marker in colon and gastric cancers as well as in other gastrointestinal malignancies although this study didn’t include esophageal cancers [27]. This evidence concerns the gene IL10 and gastric cancer.